ESPB vs iPACK+ACB in Total Knee Arthroplasty

Launched by POZNAN UNIVERSITY OF MEDICAL SCIENCES · Mar 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different approaches to managing pain after knee surgery, specifically total knee arthroplasty, which is a common procedure for people with severe knee arthritis and pain. The trial will compare the effectiveness of a combination of nerve blocks called iPACK with an Adductor Canal Block to another method called ESPB. Researchers want to see which method helps patients experience less pain and recover better after their surgery.

To participate in this trial, individuals must be between 20 and 90 years old and scheduled for knee surgery under spinal anesthesia. However, people who have certain health conditions, such as bleeding disorders, those on blood-thinning medications, or those with chronic pain issues prior to surgery, won't be eligible. If you join the trial, you can expect to receive one of the two pain management treatments and will be monitored for your pain levels and overall recovery after your knee surgery. This study is not yet recruiting participants, but it aims to find better ways to help patients manage pain after knee operations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with ASA classification I-III, Aged 20-90 years, Who will be scheduled for knee arthroplasty under spinal anaesthesia.
• Exclusion Criteria:
• • patients who have a history of bleeding diathesis,
• • take anticoagulant therapy,
• • have a History of chronic pain before surgery,
• • have Multiple trauma, cannot assess their pain (dementia),
• • have been operated on under general anaesthesia,
• • have an infection in the area and do not accept the procedure